Home
Conditions
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma

Clinical trial condition

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma

Explore clinical trials studying Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

18 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma trial results

Completed

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

NCT00939627

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Emory University/Winship Cancer Institute Atlanta, Georgia, United States

Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

Suburban Hospital Bethesda, Maryland, United States

View Trial Details

Completed

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

NCT02245100

Conditions: Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +50 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT01816984

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Completed

Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck

NCT01044433

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +30 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

NCT01469429

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +86 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

NCT01806675

Conditions: Adenocarcinoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, +123 more
Locations: Stanford University, School of Medicine Stanford, California, United States

View Trial Details

Completed

Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT02035527

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +50 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer

NCT01316757

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +35 more
Locations: Univesity of Rochester Medical Center Rochester, New York, United States

Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00095628

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Completed

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

NCT01334177

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +53 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma trial results

Related conditions